Artificial Intelligence is no longer a futuristic concept — it is transforming how the world builds, innovates, and delivers change. According to the 2025 Global AI in Project Management Survey — the ...
Healthcare experts and government officials have called for the institutionalisation of continuous quality improvement across ...
Codex gives software developers a first-rate coding agent in their terminal and their IDE, along with the ability to delegate ...
Joining strategic round alongside Cathie Wood's ARK Invest and World Proving gamers are playing against verified humans across gaming universes Investment ...
Designation supported by results from multiple dose cohorts from the Phase 1/1b trial of ficerafusp alfa in 1L HPV-negative R/M HNSCC ...
Early childhood leaders and educators' key concerns about the use of artificial intelligence (AI) in the sector came through loud and clear in recent research conducted with Storypark customers. We ...
CRAN upgraded internet speeds to 50 Mbps and donated eight computers to Gochas and Koës Libraries to bridge Namibia’s rural-urban digital divide. • The initiative supports the government’s National ...
When you search for "RPA robotic process automation software companies," this is the very question that arises in your mind.
This course offers novice designers opportunities to grasp medical device design fundamentals, understand regulatory standards, explore combination products, and enhance documentation management. It ...
The effects of transcranial direct current stimulation on cortical dynamics depend on the state of consciousness and the stimulation polarity.
Sidetrade reaches a new milestone in its global expansion. Sidetrade, a global leader in AI-powered Order-to-Cash applications, announces today that it has signed binding agreements to acquire 100% of ...
3h
LEQEMBI® IQLIK™(lecanemab-irmb) Subcutaneous Autoinjector Named to TIME's "Best Inventions of 2025"
Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") and Biogen Inc. (Nasdaq: BIIB, Headquarters: Cambridge, Massachusetts, CEO: Christopher A. Viehbacher, "Biogen") announced today that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback